> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# PZAD Designation, Review Process Guidance
- URL: https://www.fdaweb.com/pzad-designation-review-process-guidance/
- Published: 2024-06-26T12:00:00.000Z
- Updated: 2026-09-14T14:34:20.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5157258

FDA has published a guidance, *Priority Zoonotic Animal Drug Designation and Review Process*, to assist sponsors pursuing Priority Zoonotic Animal Drug (PZAD) designation of a new animal drug. The [document](https://www.fda.gov/media/174635/download?ref=fdaweb.com) is intended to provide:

- the definition of a PZAD;
- eligibility criteria for PZAD designation;
- the process for PZAD designation requests; and
- the process for expedited development and review of PZADs.

The guidance contains an Introduction, Priority Zoonotic Animal Drug, Background—The Cares Act, Priority Zoonotic Animal Drug Designation, Priority Zoonotic Animal Drug Designation Request Process, and Enhancements to Expedite the PZAD review process.